Pharma Grade Quinine Hydrochloride HCl Powder

Model NO.
LYPH-Quinine HCL Powder
Sample
Available
Other Name
Quinine Hydrochloride
MOQ
100g
Shelf Life
2 Years
Stock
Available
Appearance
White Powder
Product Name
Quinine HCl Powder
M.F.
C20h26cl2n2o2
Grade
Medicine
Transport Package
100g/500g/1kg or Customized
Specification
Quinine hydrochloride 98%
Trademark
LYPHAR
Origin
China
Production Capacity
500kg Per Month
Reference Price
$ 189.00 - 360.00
Contact Us

Product Description

Pharma Grade Quinine Hydrochloride HCL Powder

Pharma Grade Quinine Hydrochloride HCl Powder


Pharma Grade Quinine Hydrochloride HCl Powder

Product Name

 Quinine HCL Powder

Appearance

White Powder

Purity

 99%

CAS

 60-93-5

Certificate

 KOSHER,ISO9001

 

Quinine HCL Powder is an alkaloid of cinchona that was once widely used to control and prevent malaria; it also has analgesic, antipyretic, mild oxytocic, cardiac depressant, and sclerosing properties, and it decreases the excitability of the motor end plate. It is used as the dihydrochloride, hydrochloride, or sulfate salt in the treatment of resistant falciparum malaria.

 

Quinine HCL Powder can cause abnormal heart rhythms, and should be avoided if possible in patients with atrial fibrillation, conduction defects or heart block. Quinine can cause hemolysis in G6PD deficiency (an inherited deficiency), but this risk is small and the physician should not hesitate to use quinine in patients with G6PD deficiency when there is no alternative.

Pharma Grade Quinine Hydrochloride HCl Powder

Pharma Grade Quinine Hydrochloride HCl Powder






Pharma Grade Quinine Hydrochloride HCl Powder

 

Quinine HCL is also useful in some muscular disorders, especially nocturnal leg cramps and myotonia congenita, because of its direct effects on muscle membrane and sodium channels. The mechanisms of its antimalarial effects are not well understood.
Pharma Grade Quinine Hydrochloride HCl Powder

Pharma Grade Quinine Hydrochloride HCl Powder

Pharma Grade Quinine Hydrochloride HCl Powder


 

 

Pharmaceutical Intermediate

GOUV.NE, 2023